Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Evoke Pharma Inc. buy DomRuinart

Evoke Pharma Inc.
Start price
€32.66
18.11.20 / 50%
Target price
€60.00
18.11.21
Performance (%)
-3.60%
End price
€31.49
30.11.20
Summary
This prediction ended on 30.11.20 with a price of €31.49. With a performance of -3.60%, the BUY prediction by DomRuinart finished with a loss. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Evoke Pharma Inc. - - - -
iShares Core DAX® 2.992% 3.220% 4.271% 53.697%
iShares Nasdaq 100 -1.584% -3.172% 24.749% 76.697%
iShares Nikkei 225® -2.254% -9.924% 43.518% 60.793%
iShares S&P 500 -0.009% 1.641% 20.967% 62.807%

According to DomRuinart what are the pros and cons of Evoke Pharma Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by DomRuinart for this prediction

In the thread Evoke Pharma Inc. diskutieren
Prediction Buy
Perf. (%) -3.60%
Target price 5.000
Change
Ends at 18.11.21

Buy mit Kursziel 5,0

DomRuinart 
0
Report Share
18.11.20
In the thread Trading Evoke Pharma Inc.
Prediction Buy
Perf. (%) -3.60%
Target price 5.000
Change
Ends at 18.11.21

Buy beendet

DomRuinart 
0
Report Share
30.11.20